Asana BioSciences Relocates Operations To Lawrenceville, New Jersey
08/24/2016
“This move was necessary to further our vision of building an oncology-focused biopharmaceutical company,” said Sandeep Gupta, Ph.D., president and chief executive officer of Asana BioSciences. “As we continue to expand and grow, our new Princeton area location makes it ideal for us to attract key scientific and medical talent within the Central New Jersey and Philadelphia life sciences corridor.”
According to company officials, Asana continues to advance its portfolio of differentiated targeted therapies to help address major unmet medical needs, including a novel CYP17 inhibitor for prostate cancer and a dual Syk/JAK inhibitor for non-Hodgkin’s lymphoma that are in phase I/II clinical trials.
Asana BioSciences, an independent member of The Amneal Alliance of companies, is a research and development company, specializing in the discovery and development of novel drug candidates, including an antibody-drug conjugate. Asana’s portfolio consists of multiple early-stage development candidates in a variety of therapeutic areas, including oncology, pain and inflammation, among others. Over the past year, it has been adding key talent to its team, including the appointment of a chief medical officer and expansion of its scientific advisory board.
Project Announcements
Fluid Cooling Systems Expands Burton, Michigan, Operations
04/24/2025
Fiserv Plans Overland Park, Kansas, Operations
04/22/2025
Custom Air Handling Solutions Expands Burton, Michigan, Manufacturing Operations
04/22/2025
AgriAmerica Fruit Products Expands Chautauqua County, New York, Operations
04/22/2025
The Hershey Company Expands Dauphin, Pennsylvania, Operations
04/21/2025
Delta Star Expands Lynchburg, Virginia, Manufacturing Operations
04/21/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
The Location Economics of Advanced Nuclear
Q1 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Designing Beyond the Assembly Line
Q1 2025